{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-027858","form_type":"8-K","ticker":"DYAI","cik":"0001213809","company_name":"DYADIC INTERNATIONAL INC","filed_at":"2023-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.447581+00:00","generated_at":"2026-06-10T03:15:07.780414+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Dyadic partners with MGH VIC and Voltron for vaccine antigens; part of $5.88M DoD award","bullets":["Dyadic’s C1 platform to express vaccine antigens for influenza A and other infectious diseases.","Collaboration stems from a $5.88M DoD award to VIC for Self-Assembling Vaccine platform.","Aims to enable scalable, rapid vaccine production in 100 days or less at flexible scales.","Potential commercial revenue for Dyadic if products are brought to market.","Partners include Vaccine and Immunotherapy Center at MGH and Voltron Therapeutics."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-027858","json":"https://secwatch.observer/filing/0001437749-23-027858.json","markdown":"https://secwatch.observer/filing/0001437749-23-027858.md","text":"https://secwatch.observer/filing/0001437749-23-027858.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213809/000143774923027858/0001437749-23-027858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213809/000143774923027858/dyai20231004_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:15:07.780414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}